Andrew Hack


Andrew Hack is a Managing Director of Bain Capital Life Sciences. Before joining Bain Capital, he was the Chief Financial Officer of Editas Medicine from July 2015 through March 2019. Prior to that, Dr. Hack served as a portfolio manager at Millennium Management, where he ran a healthcare hedge fund focused on biotechnology, pharmaceutical, and ...

Roles at Xilio Therapeutics

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.